Dangers of Diabetes Drug Avandia are Documented, Says St. Louis Attorney Jeff Singer
Personal injury lawyer with Fox Goldblatt & Singer says forthcoming FDA report closes the case on the diabetes drug
FDA Reports Recommend Pulling Diabetes Drug Avandia Because It May Be Causing Heart Attacks
GlaxoSmithKline's Type 2 diabetes drug Avandia is in the spotlight again, drawing attention from personal injury law watchers.
Sokolove Blasts GlaxoSmithKline Over Avandia Recall
James Sokolove, Chairman of Sokolove La today blasted GlaxoSmithKline over reports of a potential recall of popular diabetes drug Avandia.
Related Articles:
LegalView Offers Mesothelioma Blog Readers Details of Disconcerting Request to Decrease Asbestos Regulations from Industry
LegalView informed mesothelioma blog readers of an potentially troubling request by automotive, chemical and mining industries' paid researchers to "water down" asbestos regulations. The industry-hired scientists argued that asbestos is no longer as dangerous, even though several international health organizations have declared no safe level of the material.
LegalView Updates Avandia Information Portal With New Articles Detailing Potentially Dangerous Side Effects
LegalView continued to maintain its newsworthy coverage on its Avandia information portal with the recent addition of several new articles detailing the drug's potentially dangerous side effects. The type 2 diabetes drug has been linked to bone fracture, osteoporosis and heart failure among patients.
LegalView Reports on Details of FDA Warning to Avandia Manufacturer for Withholding Avandia Study Research
LegalView recently reported the FDA warning letter given to manufacturers of Avandia for withholding post-market research. GlaxoSmithKline failed to comply with FDA regulations and offer officials full details of 10 ongoing clinical trials.
Public Citizen Petitions FDA to Ban Diabetes Drug Avandia, According to Avandia Plaintiffs Attorney Group
National non-profit organization documents upsurge in negative clinical data associated with use of Avandia, urges FDA commissioner to remove drug from U.S. market immediately